Wendell Amy McBride

Director Wendell Amy McBride purchased 1,475 shares of SOLV at $68.03; stock down 21.5% from 52-week high.

Director Wendell Amy McBride purchased 1,475 shares at $68.03, increasing holdings by 41.4% from 3,564 to 5,039 shares. The transaction occurs as SOLV trades 21.5% below its 52-week high of $86.14 and has declined 13.4% over the prior 30 days. McBride's cross-ticker track record shows one prior buy with an average 90-day return of +11.5% and a 100% win rate, though with only one prior comparable transaction this baseline offers limited statistical weight. The company's valuation metrics—P/E of 4.51 and $1.3B in latest quarterly net income against an $11.7B market cap—present relatively compressed multiples in the current market environment.

Director Wendell Amy McBride sold 43,684 shares at $29.31 for $1.3M on 2025-12-16, reducing stake by 31.8%.

Director Wendell Amy McBride executed 3 separate sales totaling 43,684 shares for $1,280,465.41, reducing his holdings from 137,510 shares to 93,826 shares (a net reduction of 31.8%). The sales occurred at $29.31 per share while the stock currently trades at $31.39, just 5.8% below its 52-week high of $33.32. The timing is noteworthy: the stock has surged 33.2% over the past 30 days and 81.9% over the past 90 days, placing the sale near the upper end of recent price momentum. McBride's prior transaction at AXGN (a buy on 2023-09-06) showed a 90-day return of 11.5%, though that trade occurred in a different market context. AXGN remains unprofitable on a full-year basis despite recent revenue growth of 17.8%, which may inform the decision to liquidate a material portion of a sizable position.